// App-Quantinova.ai

Su1021 : Use of Oral Bisphosphonates and Risk of Colorectal Cancer: a Systemic Review and Meta-Analysis

Researchers

Presenter

  • Sonali Thosani

Principal Investigators

  • Sheetanshu Kumar

  • Zoann Nugent

  • Camilo Jimenez

  • Harminder Singh

  • Sushovan Guha

Medical Centers

  • Internal Medicine and Community Health Sciences and IBD Clinical and Research Center, The University of Manitoba, Winnipeg, MB, Canada

  • Endocrinology, The Baylor College of Medicine, Houston, TX

  • Gastroenterology, Hepatology and Nutrition, University of Texas - Houston Medical School, Houston, TX

  • Endocrine Neoplasia and Hormonal Disorders, Univ of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Gastroenterology, Hepatology & Nutrition, MD Anderson Cancer Center, Houston, TX

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim